Expression of integrins of the beta1 family in thyroid cells from patients with Graves' disease in vivo and in vitro.
The expression of the beta1 family of integrins was determined in thyroid follicular cells from patients with Graves' disease (GD). Integrin expression was quantitated by flow fluorocytometry of single cell suspensions with antibodies against the common beta1 chain and the alpha1-alpha6 subunits. Results indicated that also in thyroid glands of GD, as previously observed in nodular goiters, two follicular cell populations with different patterns of beta1 integrin expression coexist (VLAalpha3beta1 and VLAalpha1,3,5,6beta1). The VLAalpha1,3,5,6beta1 thyrocyte population in GD was more abundant than in nodular goiters, ranging from 40 to 70% of the total follicular cells and the overall expression of the beta1 integrins was a two-fold higher. In thyrocytes from patients with GD cultured in vitro, alpha3 and alpha2 expression was regulated by cell-to-cell contact as previously described in normal thyroid cells, while the expression of alpha1, alpha5 and alpha6 was quickly lost during the culture. Our data suggest that the integrin profile of the VLAalpha1,3,5,6beta1 thyrocyte population in GD is induced by micro-environmental conditions rather than being the expression of a constitutive phenotype.
Vitale
M
M
Dipartimento di Biologia e Patologia Cellulare e Molecolare, Università Federico II, Naples, Italy.
De Riu
S
S
Fenzi
G F
GF
Casamassima
A
A
Salzano
S
S
Müeller
F
F
Marzano
L A
LA
Rossi
G
G
D002478:Cells, Cultured; D005434:Flow Cytometry; D005470:Fluorometry; D006111:Graves Disease / Q000276:immunology*; D006801:Humans; D019012:Integrin beta1 / Q000096:biosynthesis*; D013961:Thyroid Gland / Q000166:cytology / Q000276:immunology*
D019012:Integrin beta1